| Dual-time-point imaging and delayed-time-point fluorodeoxyglucose-PET/computed tomography imaging in various clinical settings S Houshmand, A Salavati, EA Segtnan, P Grupe, PF Høilund-Carlsen, ... PET clinics 11 (1), 65-84, 2016 | 59 | 2016 |
| 18F-fluorodeoxyglucose PET/computed tomography for primary brain tumors EA Segtnan, S Hess, P Grupe, PF Høilund-Carlsen PET clinics 10 (1), 59-73, 2015 | 25 | 2015 |
| How to assess intra-and inter-observer agreement with quantitative PET using variance component analysis: a proposal for standardisation O Gerke, MH Vilstrup, EA Segtnan, U Halekoh, PF Høilund-Carlsen BMC Medical Imaging 16, 1-9, 2016 | 20 | 2016 |
| Prognostic implications of total hemispheric glucose metabolism ratio in cerebrocerebellar diaschisis EA Segtnan, P Grupe, JO Jarden, O Gerke, J Ivanidze, SB Christlieb, ... Journal of Nuclear Medicine 58 (5), 768-773, 2017 | 12 | 2017 |
| Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer’s disease and mild cognitive impairment EA Segtnan, A Majdi, C Constantinescu, P Grupe, O Gerke, H Dali, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 1164-1174, 2019 | 7 | 2019 |
| Global and regional brain glucose metabolism decline after systemic chemotherapy S Gholami, EA Segtnan, A Alavi European Journal of Nuclear Medicine and Molecular Imaging 42, 981-983, 2015 | 3 | 2015 |
| Inter-observer variability using ROVER® software for processing of cerebral FDG-PET studies E Segtnan, S Christlieb, S Hess, T Nguyen, A Alavi, P Hoeilund-Carlsen Journal of Nuclear Medicine 56 (supplement 3), 1755-1755, 2015 | 2 | 2015 |
| Diagnostic implications of neuronal network diaschisis in patients with Parkinson's disease A Majdi, C Constantinescu, K Pedersen, L Wermuth, A Gjedde, E Segtnan Journal Of Cerebral Blood Flow And Metabolism 39, 565-565, 2019 | 1 | 2019 |
| Methods for Evaluating Medical Tests and Biomarkers: Birmingham, UK. 19–20 July 2016 G Gopalakrishna, M Langendam, R Scholten, P Bossuyt, M Leeflang, ... Diagnostic and prognostic research 1, 1-34, 2017 | 1 | 2017 |
| Clinical performance of AI-integrated risk assessment pooling reveals cost savings even at high prevalence of COVID-19 F Kamari, E Eller, ME Bøgebjerg, IM Capella, BA Galende, T Korim, ... Scientific Reports 14 (1), 8853, 2024 | | 2024 |
| Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive … P Grupe, O Gerke, J Holm, EA Segtnan, C Constantinescu, ... European Journal of Nuclear Medicine & Molecular Imaging 46 (5), 2019 | | 2019 |
| Diagnostic implications of total hemispheric glucose metabolism ratio in Mild cognitive impairment and Alzheimer's disease EA Segtnan, A Majdi, C Constantinescu, P Grupe, H Dali, O Strom, J Holm, ... European Journal Of Nuclear Medicine And Molecular Imaging 44, S597-S598, 2017 | | 2017 |
| Evaluation of MRI tumor characteristics and quantitative FDG-PET assessments of cerebro-cerebellar diaschisis: Pathophysiologic implications for gliomas EA Segtnan, J Holm, JH Decker, C Constantinescu, A Gjedde, ... JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 37, 245-245, 2017 | | 2017 |
| Intra-and interrater agreement with quantitative positron emission tomography measures using variance component analysis O Gerke, MH Vilstrup, EA Segtnan, U Halekoh, PF Høilund-Carlsen Diagnostic and Prognostic Research 2017 (1 (suppl 1)), O21, 2017 | | 2017 |
| Intra-and Interobserver Agreement with Quantitative PET Measures: Deriving Repeatability Coefficients from Variance Component Analysis O Gerke, MH Vilstrup, EA Segtnan, U Halekoh, PF Høilund-Carlsen European Journal of Nuclear Medicine and Molecular Imaging 43 (Suppl. 1), 496, 2016 | | 2016 |
| Total hemispheric glycolysis ratio by FDG-PET/CT in gliomas; Evaluating diaschisis and potential prognostic information EA Segtnan, P Grupe, O Gerke, JO Jarden, SB Christlieb, ... 29th Annual Congress of the European Association of Nuclear Medicine, 2016 | | 2016 |
| Errors in data recording in cerebral FDG-PET/CT scans: Consequences for quantitative outcome when measuring whole brain glycolysis EA Segtnan, SB Christlieb, O Gerke, PF Høilund-Carlsen 29th Annual Congress of the European Association of Nuclear Medicine, 2016 | | 2016 |
| Repeat assessment of total hemispheric glycolysis by FDG-PET/CT: Variability with reuse of baseline masks defined by dedicated software EA Segtnan, SB Christlieb, P Grupe, O Gerke, PF Høilund-Carlsen 29th Annual Congress of the European Association of Nuclear Medicine, 2016 | | 2016 |
| Inter-observer variability of total hemispheric glycolysis ratio obtained at 1-hour and 3-hour FDG-PET/CT imaging in glioma patients EA Segtnan, C Constantinescu, J Holm, P Grupe, O Gerke, ... European Journal of Nuclear Medicine and Molecular Imaging 43 (Suppl. 1), 263-64, 2016 | | 2016 |
| A PET method for quantification of total hemispheric glycolysis and diaschisis: A Case report in a patient with stroke 13 years ago EA Segtnan, CN Strandholt, A Gjedde, PF Høilund-Carlsen | | 2016 |
